Ignite Creation Date:
2024-05-06 @ 7:16 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05950308
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2023-07-14
Brief Title:
Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2023-07-14
First Submit QC Date:
July 14 2023
Study First Post Date:
2023-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-14
Last Update Post Date:
2023-07-18
Last Update Post Date Type:
ACTUAL